Civic Intelligence

Cohen Veterans Bioscience Inc.

990 • Fiscal year 2021 • EIN 47-1981973

Jul 01, 2020 to Jun 30, 2021 • Filed on Nov 23, 2021

Organization ProfileWWW.COHENVETERANSBIOSCIENCE.ORG

View Organization Page

1 Broadway 14th FloorCambridge, MA 02142

(646) 970-4325

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

69th percentile

0.38x

Higher debt load relative to assets than 69% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2021

Liabilities / Revenue

66th percentile

0.42x

Higher debt load relative to revenue than 66% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2021

Net Margin

11th percentile

-11%

Higher net margin than 11% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2021

Top Officer Pay

94th percentile

$644,597

Higher top officer pay than 94% of similar nonprofits.

Top officer pay equals 4.0% of source-year revenue.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2021

Asset Growth

11th percentile

-4.8%

Faster asset growth than 11% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2020 to 2021

Revenue Growth

27th percentile

-1.3%

Faster revenue growth than 27% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2020 to 2021

Balance Sheet
Liabilities / Assets69th percentile

Assets

Down

$17,952,584

Down $912,872 (-4.8%) from 2020

Net Assets

Up

$11,126,061

Up $692,365 (+6.6%) from 2020

Liabilities

Down

$6,826,523

Down $1,605,237 (-19%) from 2020

Revenue And Expenses
Liabilities / Revenue66th percentileNet Margin11th percentile

Revenue

Down

$16,252,270

Down $218,395 (-1.3%) from 2020

Expenses

Down

$18,110,420

Down $52,500 (-0.3%) from 2020

Net Income

Down

-$1,858,150

Down $165,895 (-9.8%) from 2020

Historical Trend

Balance Sheet Trend

Asset Growth11th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$30M$20M$10M$0-$10MAssets 2015: $450,595Liabilities 2015: $326,443Net Assets 2015: $124,1522015Assets 2016: $25,419,016Liabilities 2016: $10,161,873Net Assets 2016: $15,257,1432016Assets 2017: $14,863,415Liabilities 2017: $6,579,459Net Assets 2017: $8,283,9562017Assets 2018: $16,353,364Liabilities 2018: $6,020,527Net Assets 2018: $10,332,8372018Assets 2019: $24,190,269Liabilities 2019: $12,988,921Net Assets 2019: $11,201,3482019Assets 2020: $18,865,456Liabilities 2020: $8,431,760Net Assets 2020: $10,433,6962020Assets 2021: $17,952,584Liabilities 2021: $6,826,523Net Assets 2021: $11,126,0612021Assets 2022: $15,587,351Liabilities 2022: $3,699,826Net Assets 2022: $11,887,5252022Assets 2023: $11,743,398Liabilities 2023: $3,853,705Net Assets 2023: $7,889,6932023Assets 2024: $3,075,275Liabilities 2024: $3,105,844Net Assets 2024: -$30,5692024Assets 2025: $1,835,419Liabilities 2025: $98,368Net Assets 2025: $1,737,0512025

Highlighted filing

2021

Assets$17,952,584
Liabilities$6,826,523
Net Assets$11,126,061
Open 2021 Filing

Operations Trend

Revenue Growth27th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$30M$20M$10M$0-$10MRevenue 2015: $70,035Expenses 2015: $651,553Net Income 2015: -$581,5182015Revenue 2016: $31,399,759Expenses 2016: $16,266,768Net Income 2016: $15,132,9912016Revenue 2017: $4,366,629Expenses 2017: $11,339,816Net Income 2017: -$6,973,1872017Revenue 2018: $16,845,541Expenses 2018: $14,796,660Net Income 2018: $2,048,8812018Revenue 2019: $21,039,448Expenses 2019: $20,170,937Net Income 2019: $868,5112019Revenue 2020: $16,470,665Expenses 2020: $18,162,920Net Income 2020: -$1,692,2552020Revenue 2021: $16,252,270Expenses 2021: $18,110,420Net Income 2021: -$1,858,1502021Revenue 2022: $18,082,398Expenses 2022: $17,523,784Net Income 2022: $558,6142022Revenue 2023: $11,343,534Expenses 2023: $15,341,366Net Income 2023: -$3,997,8322023Revenue 2024: $8,377,751Expenses 2024: $14,079,910Net Income 2024: -$5,702,1592024Revenue 2025: $3,369,809Expenses 2025: $1,377,761Net Income 2025: $1,992,0482025

Highlighted filing

2021

Revenue$16,252,270
Expenses$18,110,420
Net Income-$1,858,150
Open 2021 Filing
Jump To
Filing Snapshot
Filing Period
Jul 1, 2020 to Jun 30, 2021
Signed
Nov 23, 2021
Return Version
2020v4.1
Gross Receipts
$16,252,270
Mission and Program Overview

Mission

Cohen veterans bioscience is the only 501(c)3 non-profit research organization with a singular focus on ptsd and tbi research. We are dedicated to fast-tracking the development of diagnostic tests and personalized medicines for the millions of veterans and civilians who suffer the devastating effects of trauma on the brain.

Biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$15,130,098$11,484,429▼ $3,645,669
Pledges and Grants Receivable$2,302,389$4,776,718▲ $2,474,329
Cash and Non-Interest-Bearing Accounts$690,470$654,129▼ $36,341
Prepaid Expenses and Deferred Charges$88,022$268,785▲ $180,763
Land, Buildings, and Equipment, Net$284,318$234,254▼ $50,064
Total Assets$18,865,456$17,952,584▼ $912,872
Other Assets Total$370,159$534,269▲ $164,110
Liabilities
Grants Payable$5,348,290$4,606,870▼ $741,420
Accounts Payable and Accrued Expenses$2,942,644$2,078,653▼ $863,991
Other Liabilities$131,804$141,000▲ $9,196
Deferred Revenue$9,022--
Total Liabilities$8,431,760$6,826,523▼ $1,605,237
Net Assets / Fund Balance
Net Assets With Donor Restrictions$7,387,725$7,705,967▲ $318,242
Net Assets Without Donor Restrictions$3,045,971$3,420,094▲ $374,123
Total Net Assets Fund Balance$10,433,696$11,126,061▲ $692,365
Total Liabilities and Net Assets / Fund Balance$18,865,456$17,952,584▼ $912,872

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$128,113$45,963$174,076
Leasehold Improvements$104,861$29,501$134,362
Other Land Buildings$1,280$10,237$11,517
Compensation and Service Providers
Top Officer Pay94th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Magali Haas Md PhdCEO & PresidentFT$467,497$177,100$644,597
Allyson Gage PhdChief Medical OfficerFT$369,048$150,710$519,758
Andreas Jeromin PhdChief Scientific OfficerFT$351,403$153,785$505,188
Daniel PlowdenFormer Chief Financial OfficerFT$267,283$125,374$392,657
Amanda Nicole HarmonExecutive Director, Community PartnershipsFT$300,586$37,961$338,547
Amanda Nicole HarmonExecutive Director, Community Partne-$251,661$86,886$338,547
Maryan ZirkleExecutive Director, BraincommonsFT$228,024$55,566$283,590
Timothy VaughanDeputy Director, Data SciencesFT$203,195$43,599$246,794
Lee LancashireChief Information OfficerFT$207,380$36,818$244,198
Lauren GoldsmithSenior Director, Contracting & Grants ManagementFT$208,155$19,451$227,606
Lauren GoldsmithSenior Director, Contracting & Grant-$207,155$20,451$227,606
Evgeny RakhmatulinChief Technology OfficerFT$160,483$63,445$223,928
David BiondiBoard Member/former Ed, Clinical ProgramFT$120,489$13,022$133,511

Board Members and Trustees

NameTitle
Dave DemarcoBoard Member
Douglas HaynesBoard Member
Theresa FrangiosaSecretary
Michael SullivanTreasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Hitachi Vantara LLCCloud-based Architecture Build And Manag2535 AUGUSTINE DRIVE, Santa Clara, CA 95054-3003, Uk$2,485,945
Grf Cpa's & AdvisorsAccounting And Bookkeeping4550 MONTGOMERY AVENUE SUITE 800, North Bethesda, MD 20814$422,062
Morgan Lewis And Bockius LLPLegal Services1500 SPRING GARDEN STREET, Philadelphia, PA 19130-4067$388,757
Clarivate Analytics US LLCLsps Discovery And Translational117 PARK DRIVE UNIT 20, Boston, MA 02215$383,670
MetacellBrain Commons Program Manangement Suppor-$366,077
Revenue and Support

Revenue Composition

Contributions and Grants
$16,160,581
Program Service Revenue
$0
Investment Income
$59,585
Other Revenue
$32,104
All Other Contributions
$15,764,205
Change in Net Assets
$-1,858,150

Audited Revenue Reconciliation

Revenue per Audited Statements
$16,252,270
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$16,252,270
Total Revenue per Form 990
$16,252,270
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$9,371,369
Salaries, Compensation, and Employee Benefits$8,452,791
Total Fundraising Expense$676,082
Grants and Similar Amounts Paid$235,660
Professional Fundraising Fees$50,600

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Other$6,506,189$180,475$1,623$6,688,287
Other Salaries and Wages$4,038,095$355,145$410,370$4,803,610
Current Officers, Directors, Trustees, and Key Employees$2,149,177$368,631$100,294$2,618,102
Occupancy$453,435$85,201$23,531$562,167
Payroll Taxes$353,963$43,218$30,733$427,914
Information Technology$315,067$106,405$3,780$425,252
Office Expenses$222,977$177,864$6,189$407,030
Fees for Services Accounting-$358,370-$358,370
Fees for Services Legal$316,752$24,631-$341,383
Other Employee Benefits$279,001$34,515$24,917$338,433
Fees for Services Management-$307,964-$307,964
Pension Plan Contributions$219,927$26,404$18,401$264,732
Foreign Grants$182,060--$182,060
Fees for Services Lobbying$90,000--$90,000
Insurance$28,862$31,294$2,506$62,662
Grants to Domestic Orgs$53,600--$53,600
Fees for Services Professional Fundraising--$50,600$50,600
Depreciation Depletion$42,514$4,412$3,138$50,064
Travel$34,805$10,063-$44,868
Other Expenses-$27,507-$27,507
Conferences and Meetings$5,815--$5,815
Total Functional Expenses$15,292,239$2,142,099$676,082$18,110,420

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$18,110,420
Total Expenses per Audited Statements$18,110,420
Total Expenses per Form 990$18,110,420
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
University of California San DiegoLa Jolla, CA501(c)3Preclinical Modeling of Ptsd and Alcohol Abuse$64,021
Boston Va Research InstituteBoston, MA501(c)3Advancing the Study of Deployment Trauma in the Tracts Cohort$0

International Summary

Offices
0
Employees
0
Spending
$182,060

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland) - Albania, Andorra, Austria, BelgiumGrants to Recipients Located in RegionN/a00$182,060
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
Yes

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$50,600
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent$141,000
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“The board of directors reviewed and approved the form 990 prior to its filing. The form 990 was then authorized and signed by the organization's ceo & president.”

Form 990, Part VI, Section B, Line 12C

“The board of directors requires an annual declaration from all board members and senior management as to the existence and disclosure of any potential conflicts of interest. The board members sign a disclosure statement. Any potential conflicts are discussed by the dis-interested board members, while the party in potential conflict is required to leave the room. Board meeting minutes will document the discussion and decision making process. In the event of a potential conflict, procedures to obtain competitive bids and diligence on fair market value will be established.”

Form 990, Part VI, Section B, Line 15

“Cvb's executive compensation program is administered by the board of directors. The board is responsible for establishing and maintaining a competitive compensation program for the key executives of the organization. The board meets as needed to review the compensation program and make recommendations for any changes, as appropriate. A performance evaluation is conducted and reviewed each year and is intended to ensure that the compensation program falls within a reasonable range of competitive practices for comparable positions among similarly situated organizations. Following this review, the board reviews and approves, for selected key executives, base salaries and annual incentive opportunity adjustments, and objectives and goals upcoming year's annual incentive plan. The board reviews and recommends to the board salary approval and incentive awards for the ceo/president and selected key senior staff.”

Form 990, Part VI, Section C, Line 19

“Upon request and forms available through charity navigator website as well.”

Filing and Contact Details

Filer

Filer Name
Cohen Veterans Bioscience Inc
EIN
47-1981973
Phone
6469704325
Address
1 BROADWAY 14TH FLOOR, CAMBRIDGE, MA 02142

Signing Officer

Name
Magali Haas Md Phd
Title
CEO & President
Phone
6469704325
Signed
2021-11-23
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Magali Haas Md Phd
Formed
2014
Legal Domicile
Ma
Voting Board Members
6
Independent Board Members
4
Employees
40
Volunteers
15

Preparer

Firm
Smith Sullivan & Brown Pc
Address
80 FLANDERS ROAD - SUITE 200, WESTBOROUGH, MA 01581
Preparer
Sandra M Brown CPA
Phone
5088717178
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Research collaboration expenses: program service expenses 1,866,118. Management and general expenses 0. Fundraising expenses 0. Total expenses 1,866,118. Contracted services: program service expenses 4,640,071. Management and general expenses 180,475. Fundraising expenses 1,623. Total expenses 4,822,169.”

FORM 990, PART XI, LINE 9:

“Cancellation of grant obligation 2,550,515.”

Financial Statement Notes

PART X, LINE 2:

“Tax position: the organization currently evaluates all tax positions, and makes a determination regarding the likelihood of those positions being upheld under review. The primary tax position made by the organization is the existence of unrelated business income tax and the organization's status as a tax-exempt organization under section 501(c)(3) of the internal revenue code. For the year presented, the organization has not recognized any tax benefits or loss contingencies for uncertain tax positions based on this evaluation.”

Raw XML AppendixShowing 400 of 868 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt02942644
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt02078653
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS.
IRS990/AllOtherContributionsAmt015764205
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0GELMAN ROSENBERG AND FREEDMAN CPA
IRS990/BooksInCareOfDetail/PhoneNum03019519090
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt04550 MONTGOMERY AVENUE SUITE 650N
IRS990/BooksInCareOfDetail/USAddress/CityNm0BETHESDA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020814
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0690470
IRS990/CashNonInterestBearingGrp/EOYAmt0654129
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt011
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt0100294
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0368631
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt02149177
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt02618102
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt05815
IRS990/ConferencesMeetingsGrp/TotalAmt05815
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContractorCompensationGrp/CompensationAmt02485945
IRS990/ContractorCompensationGrp/CompensationAmt1422062
IRS990/ContractorCompensationGrp/CompensationAmt2388757
IRS990/ContractorCompensationGrp/CompensationAmt3383670
IRS990/ContractorCompensationGrp/CompensationAmt4366077
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt01701 MARKET STREET
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm0PHILADELPHIA
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd0UK
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ForeignPostalCd019103
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt02535 AUGUSTINE DRIVE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt14550 MONTGOMERY AVENUE SUITE 800
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt21500 SPRING GARDEN STREET
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt3117 PARK DRIVE UNIT 20
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0SANTA CLARA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1NORTH BETHESDA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm2PHILADELPHIA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm3BOSTON
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0CA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd2PA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd3MA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd0950543003
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd120814
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd2191304067
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd302215
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0HITACHI VANTARA LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1GRF CPA'S & ADVISORS
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt2MORGAN LEWIS AND BOCKIUS LLP
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt3CLARIVATE ANALYTICS US LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt4METACELL
IRS990/ContractorCompensationGrp/ServicesDesc0CLOUD-BASED ARCHITECTURE BUILD AND MANAG
IRS990/ContractorCompensationGrp/ServicesDesc1ACCOUNTING AND BOOKKEEPING
IRS990/ContractorCompensationGrp/ServicesDesc2LEGAL SERVICES
IRS990/ContractorCompensationGrp/ServicesDesc3LSPS DISCOVERY AND TRANSLATIONAL
IRS990/ContractorCompensationGrp/ServicesDesc4BRAIN COMMONS PROGRAM MANANGEMENT SUPPOR
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt016160581
IRS990/CYGrantsAndSimilarPaidAmt0235660
IRS990/CYInvestmentIncomeAmt059585
IRS990/CYOtherExpensesAmt09371369
IRS990/CYOtherRevenueAmt032104
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-1858150
IRS990/CYSalariesCompEmpBnftPaidAmt08452791
IRS990/CYTotalExpensesAmt018110420
IRS990/CYTotalFundraisingExpenseAmt0676082
IRS990/CYTotalProfFndrsngExpnsAmt050600
IRS990/CYTotalRevenueAmt016252270
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt09022
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt03138
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt04412
IRS990/DepreciationDepletionGrp/ProgramServicesAmt042514
IRS990/DepreciationDepletionGrp/TotalAmt050064
IRS990/Desc0BRAIN HEALTH PLATFORMS:IN ORDER TO FAST-TRACK PRECISION DIAGNOSTICS AND PERSONALIZED THERAPEUTICS AND WELLNESS APPROACHES FOR MAINTENANCE AND RESTORATION OF BRAIN HEALTH, CVB IS LEVERAGING INNOVATION AND TECHNOLOGY TO BUILD PLATFORMS THAT ENABLE DISCOVERY AND DEVELOPMENT ACROSS BRAIN DISEASES. THESE PLATFORMS ALLOW RESEARCHERS FROM ACADEMIA AND INDUSTRY TO ACCESS AND UTILIZE BEST-IN-CLASS TOOLS AND ALLOW EFFORTS TO BE SCALED WITH RIGOR AND REPRODUCIBILITY.(SEE SCHEDULE O FOR FULL DETAIL OF OUR PROGRAMS)PLATFORM EFFORTS FOCUS ON CAPACITY THAT ENABLES RELIABLE DISCOVERY OF BIOMARKERS AND BIOLOGICAL PATHWAYS THAT ARE TRANSLATIONALLY RELEVANT FOR THE DEVELOPMENT OF DIAGNOSTICS AND THERAPEUTIC TARGETS FOR DRUG AND OTHER MEDICAL INTERVENTIONS. EACH PLATFORM IS CREATING RESEARCH TOOLS (E.G. ANIMAL MODELS, DATA STANDARDS, COMPUTATIONAL MODELS, REFERENCE DATABASES, ETC.) THAT WILL ACCELERATE/FOSTER THESE DISCOVERIES. WITHIN THIS FRAMEWORK, CVB HAS ESTABLISHED BOTH INTRAMURAL (RESEARCH CONDUCTED BY, OR INCLUDING, CVB STAFF OR CONTRACTORS) AND EXTRAMURAL RESEARCH PROGRAMS (RESEARCH CONDUCTED VIA GRANTS OR IN COLLABORATION WITH EXTERNAL ACADEMIC, INDUSTRY, FOUNDATION AND GOVERNMENT PARTNERS) AND ALSO OPERATES SEVERAL PUBLIC-PRIVATE PARTNERSHIPS. THESE COOPERATIVE ALLIANCES ORGANIZE AND FUND A NETWORK OF PARTNERS WHO EACH CONTRIBUTE COMPLEMENTARY AND SYNERGISTIC DATA, CAPABILITIES, OR EXPERTISE TO SUPPORT A COMMON ROADMAP FOR IDENTIFYING DIAGNOSTIC BIOMARKERS, BUILDING PREDICTIVE BRAIN DISEASE MODELS, DEVELOPING ROBUST STANDARDIZED TRANSLATIONAL TOOLS, AND CATALYZING PHARMACEUTICAL DRUG DEVELOPMENT. THE EMPHASIS IS ON TEAM SCIENCE WITH COHEN VETERANS BIOSCIENCE SERVING AS ITS HUB.OUR PLATFORM PROGRAMS CURRENTLY INCLUDE THE BRAIN COMMONS (CLOUD-BASED DATA SHARING), EARLYSIGNAL (WEARABLE AND HOME SENSORS FOR MONITORING HEALTH STATUS), RAPID-DX (ESTABLISHING BEST PRACTICES FOR DISCOVERY AND VALIDATION OF BIOMARKERS) AND AMP-IT-UP (FOR PRECLINICAL DISCOVERY AND TRANSLATION).BRAINCOMMONS:WE ARE IN A NEW ERA OF BRAIN RESEARCH, WHERE POWERFUL DATA ACQUISITION TECHNOLOGIES ARE GENERATING MULTIMODAL DATA AT INCREASING SCALES. OUR PRIMARY CHALLENGE TODAY EXTENDS BEYOND DATA GENERATION; RATHER, IT LIES IN DATA UTILIZATION AND KNOWLEDGE EXTRACTION. TO ENABLE DISEASE MODELING EFFORTS, AS WELL AS THE DISCOVERY AND REPLICATION OF BIOMARKERS, THERE IS A CRITICAL NEED FOR A PLATFORM THAT CAN HOUSE MULTI-MODAL DATA TYPES, ACROSS DIAGNOSTIC CATEGORIES, IN CONJUNCTION WITH DATA PIPELINES TO ENSURE REPRODUCIBLE ANALYSIS, AND WITH AN ABILITY TO APPLY STATE-OF-THE-ART, MACHINE-LEARNING ALGORITHMS. THE BRAINCOMMONS AIMS TO DELIVER ON THIS POTENTIAL, AS THE FIRST BIG-DATA CLOUD-BASED PLATFORM FOR COMPUTATIONAL INNOVATION DISCOVERY IN BRAIN DISEASES THAT SUPPORTS RAW DATA INTEGRATION, INTEROPERABILITY BETWEEN SYSTEMS AND A DATA MODEL THAT OFFERS A COMPATIBLE FORMAT ADHERING TO COMMON STANDARDS WHERE ALL THE DATA, NO MATTER THE SIZE OR TYPE, CAN BE COMBINED FOR RE-USE, FUELING DISCOVERY AND COLLABORATION ACROSS THE MULTIDISCIPLINARY AND MULTI-SECTOR RESEARCH COMMUNITY, AND DRIVING DIAGNOSTIC AND THERAPEUTIC INNOVATION TO REDUCE THE BURDEN OF BRAIN-BASED DISORDERS. EARLYSIGNAL:WEARABLE AND SENSOR TECHNOLOGIES HOLD PROMISE IN THE ASSESSMENT AND CONTINUOUS MONITORING OF PATIENTS IN ORDER TO BETTER SCREEN AND DIAGNOSE, MONITOR DISEASE PROGRESSION, AND OBSERVE INTERVENTION RESPONSE OR LACK THEREOF. DIGITAL HEALTH MONITORING ALSO ALLOWS US TO STUDY BRAIN HEALTH AND DISEASE IN UNPRECEDENTED WAYS, BY TRACKING VARIABLES SUCH AS SLEEP, PHYSICAL ACTIVITY, STRESS AND COGNITION, WE MAY BE ABLE TO BETTER UNDERSTAND WHAT CHANGES OVER TIME, AND TO DEVELOP EARLIER AND PREVENTIVE DIAGNOSTICS AND TREATMENTS TO MAKE A DIFFERENCE IN PATIENTS' LIVES. MEDICAL-GRADE DATA IS NEEDED FOR FDA APPROVAL OF SUCH PLATFORMS FOR USE IN MEDICAL DECISION MAKING AND DATA INTEGRATION IS NECESSARY FOR CLINICIANS' WORKFLOW. THIS PROGRAM SUPPORTS MULTIPLE PARTNERS TO TEST AND VALIDATE WEARABLES, SENSORS, A
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd01
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt07387725
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt07705967
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt040
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt015292239
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0358370
IRS990/FeesForServicesAccountingGrp/TotalAmt0358370
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt024631
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0316752
IRS990/FeesForServicesLegalGrp/TotalAmt0341383
IRS990/FeesForServicesLobbyingGrp/ProgramServicesAmt090000
IRS990/FeesForServicesLobbyingGrp/TotalAmt090000
IRS990/FeesForServicesManagementGrp/ManagementAndGeneralAmt0307964
IRS990/FeesForServicesManagementGrp/TotalAmt0307964
IRS990/FeesForServicesOtherGrp/FundraisingAmt01623
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt0180475
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt06506189
IRS990/FeesForServicesOtherGrp/TotalAmt06688287
IRS990/FeesForServicesProfFundraising/FundraisingAmt050600
IRS990/FeesForServicesProfFundraising/TotalAmt050600
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt0182060
IRS990/ForeignGrantsGrp/TotalAmt0182060
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt060.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt19.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1440.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt017100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt313022
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt637374
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt714957
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt836818
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt924463
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1037961
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1119451
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1228007
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1321099
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1414166
IRS990/Form990PartVIISectionAGrp/PersonNm0MAGALI HAAS MD PHD
IRS990/Form990PartVIISectionAGrp/PersonNm1THERESA FRANGIOSA
IRS990/Form990PartVIISectionAGrp/PersonNm2MICHAEL SULLIVAN
IRS990/Form990PartVIISectionAGrp/PersonNm3DAVID BIONDI
IRS990/Form990PartVIISectionAGrp/PersonNm4DOUGLAS HAYNES
IRS990/Form990PartVIISectionAGrp/PersonNm5DAVE DEMARCO
IRS990/Form990PartVIISectionAGrp/PersonNm6DANIEL PLOWDEN
IRS990/Form990PartVIISectionAGrp/PersonNm7ANDREAS JEROMIN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm8LEE LANCASHIRE
IRS990/Form990PartVIISectionAGrp/PersonNm9ALLYSON GAGE PHD
IRS990/Form990PartVIISectionAGrp/PersonNm10AMANDA NICOLE HARMON
IRS990/Form990PartVIISectionAGrp/PersonNm11LAUREN GOLDSMITH
IRS990/Form990PartVIISectionAGrp/PersonNm12EVGENY RAKHMATULIN
IRS990/Form990PartVIISectionAGrp/PersonNm13TIMOTHY VAUGHAN
IRS990/Form990PartVIISectionAGrp/PersonNm14MARYAN ZIRKLE
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0627497
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt3120489
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt6355283
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt7490231
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8207380
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9495295
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10300586
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11208155
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12195921
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt13225695
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt14269424
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO & PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3BOARD MEMBER/FORMER ED, CLINICAL PROGRAM
IRS990/Form990PartVIISectionAGrp/TitleTxt4BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt6FORMER CHIEF FINANCIAL OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt7CHIEF SCIENTIFIC OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt8CHIEF INFORMATION OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt9CHIEF MEDICAL OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt10EXECUTIVE DIRECTOR, COMMUNITY PARTNERSHIPS
IRS990/Form990PartVIISectionAGrp/TitleTxt11SENIOR DIRECTOR, CONTRACTING & GRANTS MANAGEMENT
IRS990/Form990PartVIISectionAGrp/TitleTxt12CHIEF TECHNOLOGY OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt13DEPUTY DIRECTOR, DATA SCIENCES
IRS990/Form990PartVIISectionAGrp/TitleTxt14EXECUTIVE DIRECTOR, BRAINCOMMONS
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02014
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt06
IRS990/GovernmentGrantsAmt0396376
IRS990/GrantAmt0235660
IRS990/GrantsPayableGrp/BOYAmt05348290
IRS990/GrantsPayableGrp/EOYAmt04606870
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt053600
IRS990/GrantsToDomesticOrgsGrp/TotalAmt053600
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt016252270
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt04
IRS990/IndivRcvdGreaterThan100KCnt029
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt03780
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt0106405
IRS990/InformationTechnologyGrp/ProgramServicesAmt0315067
IRS990/InformationTechnologyGrp/TotalAmt0425252
IRS990/InsuranceGrp/FundraisingAmt02506
IRS990/InsuranceGrp/ManagementAndGeneralAmt031294
IRS990/InsuranceGrp/ProgramServicesAmt028862
IRS990/InsuranceGrp/TotalAmt062662
IRS990/InvestmentIncomeGrp/ExclusionAmt059585
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt059585
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt045
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt085701
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0284318
IRS990/LandBldgEquipBasisNetGrp/EOYAmt0234254
IRS990/LandBldgEquipCostOrOtherBssAmt0319955
IRS990/LegalDomicileStateCd0MA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0COHEN VETERANS BIOSCIENCE, INC. IS A NON-PROFIT 501(C)(3) BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt010433696
IRS990/NetAssetsOrFundBalancesEOYAmt011126061
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt03045971
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt03420094
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt023531
IRS990/OccupancyGrp/ManagementAndGeneralAmt085201
IRS990/OccupancyGrp/ProgramServicesAmt0453435
IRS990/OccupancyGrp/TotalAmt0562167
IRS990/OfficeExpensesGrp/FundraisingAmt06189
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0177864
IRS990/OfficeExpensesGrp/ProgramServicesAmt0222977
IRS990/OfficeExpensesGrp/TotalAmt0407030
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0370159
IRS990/OtherAssetsTotalGrp/EOYAmt0534269
IRS990/OtherChangesInNetAssetsAmt02550515
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt024917
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt034515
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0279001
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0338433
IRS990/OtherExpensesGrp/Desc0BAD DEBT EXPENSE
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt027507
IRS990/OtherExpensesGrp/TotalAmt027507
IRS990/OtherLiabilitiesGrp/BOYAmt0131804
IRS990/OtherLiabilitiesGrp/EOYAmt0141000
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/BusinessCd1900099
IRS990/OtherRevenueMiscGrp/Desc0HRA FORFEITURES
IRS990/OtherRevenueMiscGrp/Desc1STIMULUS/COVID CREDITS
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt028475
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt13629
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt028475
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt13629
IRS990/OtherRevenueTotalAmt032104
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt0410370
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0355145
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt04038095
IRS990/OtherSalariesAndWagesGrp/TotalAmt04803610
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt030733
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt043218
IRS990/PayrollTaxesGrp/ProgramServicesAmt0353963
IRS990/PayrollTaxesGrp/TotalAmt0427914
IRS990/PensionPlanContributionsGrp/FundraisingAmt018401
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt026404
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt0219927
IRS990/PensionPlanContributionsGrp/TotalAmt0264732
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt02302389
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt04776718
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt088022
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0268785
IRS990/PrincipalOfficerNm0MAGALI HAAS MD PHD
IRS990/ProfessionalFundraisingInd01
IRS990/ProgSrvcAccomActy2Grp/Desc0BRAIN TRAUMA BLUEPRINT - STATE OF THE SCIENCE SUMMITSTHE BRAIN TRAUMA BLUEPRINT IS A SERIES OF STATE OF THE SCIENCE SUMMITS AIMED TO BUILD CONSENSUS AROUND KNOWLEDGE GAPS AND DEVELOP STRATEGIES TO MOVE THE FIELD FORWARD FOR TRAUMA-RELATED CONDITIONS BY LEVERAGING THE COMBINED INTELLECTUAL RESOURCES OF THE FULL RESEARCH COMMUNITY.THE STATE OF THE SCIENCE SUMMITS ARE DESIGNED AS RETREATS FOR 100 TO 200 STAKEHOLDERS TO COME TOGETHER TO REALIZE TRUE IMPACT. THE STAKEHOLDERS ENCOMPASS A BROAD SWATH OF THE COMMUNITY FROM ACADEMIC INSTITUTIONS TO GOVERNMENT AGENCIES, FOUNDATIONS SUPPORTING TRANSLATIONAL RESEARCH, AND INDUSTRY.EACH SUMMIT SERVES AS A LAUNCHPAD FOR ONGOING WORKING GROUPS TO DEVELOP EVIDENCE-BASED STRATEGIES AND RECOMMENDATIONS ON HOW TO FILL THOSE GAPS, IDENTIFY NEW GAPS AS OTHERS ARE FILLED, AND DISSEMINATE THESE FINDINGS BACK TO THE COMMUNITY AT LARGE THROUGH WHITE PAPERS AND PROCEEDINGS.THE INAUGURAL STATE OF THE SCIENCE SUMMIT ("SOSS"), HELD IN 2018, FOCUSED ON DIAGNOSIS OF TRAUMA-RELATED BRAIN DISORDERS WITH A MAJOR FOCUS ON POST-TRAUMATIC STRESS DISORDER. THE TRAUMA-RELATED BRAIN DISORDERS RESEARCH COMMUNITY HAS IDENTIFIED A NEED TO ESTABLISH A MECHANISM-BASED TAXONOMY FOR THESE CONDITIONS TO ADVANCE BIOMARKER DISCOVERY AS WELL AS DIAGNOSIS AND THERAPEUTIC DEVELOPMENT. A SHIFT FROM A SYNDROMIC CLASSIFICATION SYSTEM TO A MECHANISTIC ONE NECESSITATES A REVIEW OF THE CURRENT SCIENTIFIC KNOWLEDGE, ADOPTION OF NEW SCIENTIFIC MODELS, AND IDENTIFICATION OF RESEARCH AND KNOWLEDGE GAPS. THE SOSS BROUGHT TOGETHER MULTIDISCIPLINARY STAKEHOLDERS WITH DEEP SCIENTIFIC AND CLINICAL EXPERTISE TO ADDRESS THIS PRESSING NEED.THE THEME OF THE SECOND STATE OF THE SCIENCE SUMMIT, HELD IN 2019 WAS PATHS TO TREATMENT FOR TRAUMATIC BRAIN INJURY(S) WITH A FOCUS ON THE TAXONOMY AND NOSOLOGY OF THE CHRONIC SEQUELAE, CHALLENGES AND OPPORTUNITIES IN CLINICAL PRACTICE AND DEVELOPMENT, AND ETIOLOGY AND MECHANISM OF PERSISTENT SYMPTOMS. AS MEASUREMENT TOOLS ADVANCE, RESEARCH HAS BEEN ABLE TO FOCUS ON DIFFERENT TYPES OF INJURY, BEYOND THE MILD, MODERATE, AND SEVERE CLASSIFICATIONS OF TBI. TO AUGMENT AND SUPPORT THE MANY EFFORTS ACROSS FIELDS AND ORGANIZATIONS OVER THE PAST DECADE, IN 2020 WE WORKED WITH THOUGHT LEADERS ACROSS TBI TO PREPARE A CONSENSUS BLUEPRINT TO DRIVE TRANSLATIONAL SCIENCE FOR TBI. IN 2021, WE PUBLISHED SIX CONSENSUS ARTICLES FROM THE TBI SUMMIT IN THE JOURNAL OF NEUROTRAUMA OUTLINING GAPS AND RECOMMENDATIONS FOR FUTURE RESEARCH.BEST BIOMARKER PTSD STUDY:DESPITE THE EFFICACY OF PSYCHOTHERAPY AS FIRST-LINE TREATMENT FOR PTSD, LARGE INTER-INDIVIDUAL DIFFERENCES IN OUTCOMES EXIST, WITH ROUGHLY 50% OF PATIENTS RESPONDING TO TREATMENT AND FEWER THAN THAT FULLY REMITTING. THIS GRANT SUPPORTED THE DEVELOPMENT OF A RESPONSE DIAGNOSTIC TEST BASED ON PRELIMINARY FINDINGS FOR A COMBINATION COGNITIVE/IMAGING MARKER RESULTING FROM CVB'S INVESTMENT IN THE COHEN VETERANS CENTER STUDY AT NYU/STANFORD. THE PROGRAM INCLUDED A CLINICAL STUDY AT TWO CENTERS OF OVER 200 SUBJECTS TO REPLICATE THE INITIAL FINDING, AND IS SEEKING QUALIFICATION VIA THE FOOD AND DRUG ADMINISTRATION ("FDA") GUIDANCE TO SUPPORT THE COMMERCIALIZATION AND/OR AVAILABILITY OF THE TEST FOR CLINICAL PRACTICE AND RESEARCH AND DEVELOPMENT. THIS STUDY COMPLETED RECRUITMENT IN DECEMBER 2019 AND SEMINAL RESULTS WHICH DEMONSTRATE THAT AN EEG BASED BIOMARKER CAN PREDICT TREATMENT RESPONSE FOR INDIVIDUALS WITH PTSD OR MAJOR DEPRESSIVE DISORDER ("MDD") WERE PUBLISHED IN 2020 AND 2021.PTSD GENETICS PROGRAM:THE PSYCHIATRIC GENETICS CONSORTIUM-PTSD WORKING GROUP - BROAD INSTITUTE COLLABORATION IS SUPPORTING THE LARGEST GLOBAL GENOME WIDE ASSOCIATION STUDY ("GWAS") OF PTSD TO DATE WITH DATA FROM OVER 200,000 INDIVIDUALS ANALYZED. THE MAIN GOAL IS TO UNCOVER THE GENETIC UNDERPINNINGS OF PTSD RISK AND PUBLISH ALL RESULTS. SEMINAL FINDINGS OF THE FIRST PTSD GENETIC RISK LOCI FROM THIS PROGRAM WERE PUBLISHED IN NATURE COMMUNICATIONS IN OCTOBER 2019.IN 2021, MULTIPLE SECONDARY ANALYSES OF THIS
IRS990/ProgSrvcAccomActy3Grp/Desc0SOLUTIONS FOR KEY CHALLENGES AND SOURCES OF VARIATION WITHIN THESE DOMAINS ARE DISCUSSED. IN RESPONSE TO METHODOLOGICAL VARIATION IN SPS STUDIES, AN EXPERT PANEL WAS CONVENED TO GENERATE METHODOLOGICAL CONSIDERATIONS TO GUIDE RESEARCHERS IN THE APPLICATION OF SPS AND THE EVALUATION OF EXTINCTION RETENTION AS A TEST FOR A PTSD-LIKE PHENOTYPE. MANY OF THESE GUIDELINES ARE APPLICABLE TO ALL RODENT PARADIGMS DEVELOPED TO MODEL TRAUMA EFFECTS OR LEARNED FEAR PROCESSES RELEVANT TO PTSD, AND NOT LIMITED TO SPS. EFFORTS TOWARD OPTIMIZING PRECLINICAL MODEL APPLICATION ARE ESSENTIAL FOR ENHANCING THE REPRODUCIBILITY AND TRANSLATIONAL UTILITY OF PRECLINICAL MODELS FOR THERAPEUTIC RESEARCH AND DEVELOPMENT.COMPUTATIONAL MODELING & DATA SCIENCES:CVB HAS ESTABLISHED AN INTRAMURAL DATA SCIENCES PROGRAM TO BUILD MACHINE-LEARNING AND ARTIFICIAL INTELLIGENCE BASED PREDICTIVE MODELS OF DISEASE. THESE PROGRAMS BUILD ON OUR ORIGINAL ORION MS BIO-MODELLING PROGRAM AND FOCUSES ON MODELS OF PTSD, TBI, PARKINSONS AND DEMENTIA AND OTHER CONDITIONS.MULTIPLE SCLEROSIS ("MS") 1.0:THE ORION BIONETWORKS FLAGSHIP PROGRAM SUCCESSFULLY PILOTED THE ESTABLISHMENT OF A MULTIPLE SCLEROSIS BIONETWORK COMPRISED OF ACADEMIC (NEUROSCIENCE INSTITUTE OF THE BRIGHAM AND WOMEN'S HOSPITAL), ADVOCACY (ACCELERATED CURE PROJECT FOR MS), COMPUTATIONAL (GNS HEALTHCARE, METACELL, THOMSON REUTERS), INFORMATICS (CONVERGE BY DELOITTE, RANCHO BIOSCIENCES, EXAPTIVE), AND ONLINE PATIENT COMMUNITY PARTNERS (PATIENTSLIKEME [PLM]). DE-IDENTIFIED HIPPA-COMPLIANT DATA FROM THREE DATABASES WERE CURATED AND LOADED INTO A CLOUD-BASED DATA KNOWLEDGE MANAGEMENT SYSTEM. THE INTEGRATED REPOSITORY INCLUDES 9,000 SUBJECTS WITH MS AND RELATED CONDITIONS. THE ALLIANCE DEVELOPED A ROADMAP FOR JOINT EXECUTION WITH SPECIFIC SCIENTIFIC AIMS. THE ALLIANCE HAS GENERATED MULTIPLE MODELS BASED ON THE DATA REPOSITORY USING DIFFERENT ALGORITHMIC APPROACHES: PHENOTYPIC PROGNOSTIC MODEL AND TWO MOLECULAR PROGNOSTIC MODELS.PARKINSON'S PROGRESSION MARKERS INITIATIVE ("PPMI") DATA SCIENCE MODELING GROUP:EXISTING DIAGNOSES FOR COMPLEX BRAIN DISORDERS SUCH AS PARKINSON'S DISEASE FOCUS ON UNDERSTANDING CLUSTERS OF MAJOR SYMPTOMS. IN ORDER TO DRIVE PROGRESS IN THE DEVELOPMENT OF NEW TREATMENTS IT IS IMPORTANT TO UNDERSTAND THE ROLE OF SPECIFIC BIOLOGICAL PROCESSES IN DETERMINING PATIENT OUTCOMES. IN THIS PROGRAM WE MODEL THE MICHAEL J. FOX FOUNDATION ("MJFF") SPONSORED PARKINSON'S PROGRESSION MODEL INITIATIVE STUDY. THE STUDY HAS EVALUATED PARTICIPANTS' CLINICAL STATUS WHILE COLLECTING IMAGING, BEHAVIORAL, 'OMICS AND OTHER ASSESSMENTS LONGITUDINALLY SINCE 2010. IN OUR ALIGNED MISSIONS TO ADVANCE BRAIN HEALTH, MJFF SELECTED CVB'S DATA SCIENCE TEAM TO LEVERAGE THIS COHORT TOGETHER WITH A MULTI-DISCIPLINARY APPROACH TO QUANTITATIVELY EXPLORE, EVALUATE, AND PREDICT DISEASE TRAJECTORY, RISK FACTORS, AND SUBTYPES. GIVEN THE BREADTH AND DEPTH OF THE PPMI DATA AND RICH OPPORTUNITIES TO DEVELOP IMPACTFUL DISEASE MODELS, THE TEAM USE THEIR SUBJECT MATTER EXPERTISE ACROSS TRANSLATIONAL SCIENCE TO GENERATE INSIGHTS FROM 'OMICS, IMAGING, GENETIC AND CLINICAL DATA BY INTEGRATING TECHNIQUES ACROSS ADVANCED STATISTICS, MACHINE LEARNING, AND COMPUTATIONAL MODELING TO FACILITATE PD BIOMARKER DISCOVERY AND DEEPEN OUR UNDERSTANDING OF DISEASE PROGRESSION. GLOBAL PRECLINICAL DATA FORUM (TRADEMARKED):THE GLOBAL PRECLINICAL DATA FORUM ("GPDF") IS A JOINTLY SPONSORED US AND EUROPEAN INITIATIVE THAT ENCOURAGES GLOBAL COLLABORATION TO ADDRESS THE CHALLENGE OF ENSURING THAT PRECLINICAL RESEARCH IS REPRODUCIBLE, ROBUST AND TRANSLATABLE TO SUPPORT DISEASE RESEARCH UTILITY FOR CLINICAL RESEARCH & DEVELOPMENT ("R&D"). IT SUPPORTS BEST RESEARCH PRACTICES, THE DEVELOPMENT AND IMPLEMENTATION OF DATA QUALITY STANDARDS, PRECLINICAL DATA & TECHNOLOGICAL PLATFORMS, AND TRAINING PROGRAMS FOR THE NEUROSCIENCE COMMUNITY WITH THE GOAL OF ENHANCING THE DATA UTILITY DERIVED FROM PRECLINICAL MODELS. THIS IS OUR FOURTH YEAR SUPPORTING WITH THE EUROPEAN COLLEGE OF N
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt016316026
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt01112861
IRS990/PYInvestmentIncomeAmt0154639
IRS990/PYOtherExpensesAmt09950539
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-1692255
IRS990/PYSalariesCompEmpBnftPaidAmt07099520
IRS990/PYTotalExpensesAmt018162920
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt016470665
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-1858150
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt015130098
IRS990/SavingsAndTempCashInvstGrp/EOYAmt011484429
IRS990ScheduleA/FactsAndCircumstancesTestTxt0COHEN VETERANS BIOSCIENCE, INC. ("CVB") IS A PUBLIC CHARITY DEDICATED TO FAST-TRACKING THE DEVELOPMENT OF DIAGNOSTIC TESTS AND PERSONALIZED THERAPEUTICS FOR THE MILLIONS OF VETERANS AND CIVILIANS IN THE US WHO SUFFER THE DEVASTATING EFFECTS OF TRAUMA-RELATED AND OTHER BRAIN DISORDERS. GLOBALLY, 2 BILLION INDIVIDUALS ARE DIRECTLY AFFECTED BY BRAIN DISORDERS. THE WORLD HEALTH ORGANIZATION ATTRIBUTES 38% OF THE TOTAL YEARS LOST TO DEATH AND DISABILITY TO BRAIN DISORDERS, A FIGURE WELL AHEAD OF THE NEXT-CLOSEST AND HIGHER-PROFILE DISEASES OF CANCER (12.7%) AND CARDIOVASCULAR DISEASE (11.8%). THIS MEMO PROVIDES EVIDENCE OF QUANTITATIVE AND QUALITATIVE MEASURES WHICH SUPPORT CONTINUED PUBLIC CHARITY STATUS. CVB MEETS THE QUANTITATIVE PERCENTAGE TEST CRITERION FOR SUPPORTING FACTS AND CIRCUMSTANCES. CVB ENGAGES WITH AND MAKES AVAILABLE TO RESEARCHERS, POLICY MAKERS, AND THE GENERAL PUBLIC A BROAD ARRAY OF PROGRAMS, TOOLS, SERVICES, AND INFORMATION WHICH ADVANCE THE STATE OF BRAIN SCIENCE, GUIDED BY AN INDEPENDENT BOARD AND ADVISORY COUNSELS IN CONJUNCTION WITH CVB'S RENOWNED EXPERTS IN RELEVANT FIELDS OF NEUROSCIENCE, DATA SCIENCE AND PHARMACEUTICAL RESEARCH AND DEVELOPMENT. FOLLOWING ARE MORE DETAILED EVIDENCE OF THESE FACTS AND CIRCUMSTANCES. COHEN VETERANS BIOSCIENCE, INC. EARLY ORIGINS WERE AS AN ORGANIZATION UNDER THE FISCAL SPONSORSHIP OF THE MARIN COUNTY COMMUNITY FOUNDATION, LATER ESTABLISHED AS A STAND-ALONE 501(C)3 IN 2014 UNDER THE NAME ORION BIONETWORKS. CVB'S FOUNDER AND CEO HAS A PERSONAL CONNECTION TO THE PUBLIC WORK THE ORGANIZATION CARRIES OUT BY VIRTUE OF HER HUSBAND BEING A VETERAN OF THE US AIRFORCE SERVICE AND HER SISTER SERVING AS AN AIRFORCE COLONEL, WITH ACTIVE DEPLOYMENTS TO OEF/OIF. THE FORMAL NAME CHANGE TO COHEN VETERANS BIOSCIENCE TOOK PLACE IN 2015 IN CONCERT WITH GENEROUS SEED FUNDING FROM STEVEN A. COHEN. CVB QUALIFIES AS A PUBLIC CHARITY UNDER THE "FACTS AND CIRCUMSTANCES" TEST OF 1.170A-9(F)(3) OF THE TREASURY REGULATIONS, BASED UPON THE FOLLOWING:CVB IS ORGANIZED AND OPERATED SO AS TO ATTRACT NEW AND ADDITIONAL FUNDING ON A CONTINUOUS AND BONA FIDE BASIS; CVB HAS HAD DONATION BUTTON ON ITS WEBSITE AND ALL SOCIAL MEDIA SINCE INCEPTION. THE ORGANIZATION HAS RUN SEVERAL ONLINE DONATION CAMPAIGNS INCLUDING A "CROWDSOURCED" APPROACH IN 2017 THAT RAISED MORE THAN $100,000 FROM NUMEROUS INDIVIDUAL DONORS. THE ORGANIZATION HAS ACTIVELY PURSUED AND RECEIVED GRANTS FROM GOVERNMENT AND PUBLIC CHARITIES AND FOUNDATIONS FOCUSED ON BRAIN DISEASES. IN CVB'S EARLY YEARS OF EXISTENCE THE SCOPE OF ITS SOLICITATION WAS MORE LIMITED TO PERSONS DEEMED MOST LIKELY TO PROVIDE EARLY FUNDING IN AN AMOUNT SUFFICIENT TO ENABLE IT TO COMMENCE ITS CHARITABLE ACTIVITIES AND EXPAND THE SOLICITATION PROGRAM. DIRECT OUTREACH TO POTENTIAL SUPPORTERS IS INCREASINGLY CONDUCTED BY CVB'S CEO AND OTHER EXECUTIVE TEAM AND SCIENTIFIC STAFF. CVB NOW REGULARLY CONDUCTS BROAD OUTREACH CAMPAIGNS, HAS STAFF DEDICATED TO FUNDRAISING AND SUPPORTER ENGAGEMENT TO SOLICIT CHARITABLE CONTRIBUTIONS FROM THE GENERAL PUBLIC, AND CARRIES ON ACTIVITIES DESIGNED TO ATTRACT SUPPORT FROM GOVERNMENT SOURCES AND PUBLIC CHARITIES. IN FY 2021, CVB HIRED AN EXPERIENCED EXECUTIVE DIRECTOR OF DEVELOPMENT TO FURTHER EXPAND FUNDRAISING INFRASTRUCTURE AND OUTREACH. CVB REGULARLY APPLIES FOR RELEVANT FUNDING FROM GOVERNMENT AGENCIES AND NONPROFIT ORGANIZATIONS. CVB HAS DEVELOPED MATERIALS TO SUPPORT POTENTIAL DONOR ENGAGEMENT, AND WORKS DILIGENTLY TO EXPAND THE NETWORK OF POTENTIAL SUPPORTERS BY ENGAGING WITH BOARD MEMBERS AND STAFF TO CONNECT WITH THEM. CVB'S PUBLIC SUPPORT PERCENTAGE, AS REPORTED FOR 2019, WAS 10.51%, AND HAS GROWN TO 11.08% AS REPORTED FOR 2020, AND WE ANTICIPATE SIGNIFICANT FUTURE INCREASES AS A RESULT OF EXPANDED FUNDRAISING INFRASTRUCTURE AND OUTREACH. THE 2020 RESULT WHEN COMPARED TO THE 2018 PERCENTAGE OF 8.94% IS EVIDENCE OF THE INCREASING BREADTH OF PUBLIC SUPPORT AS CVB FURTHER BUILDS UPON ITS FUNDRAISING EFFORTS. CVB HAS RECEIVED SUPPORT FR
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0HRA FORFEITURES - 2020 AMOUNT: $ 28,475. STIMULUS/COVID CREDITS - 2020 AMOUNT: $ 3,629.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt1DR. HAAS HAS OVER 20 YEARS OF PHARMACEUTICAL EXECUTIVE AND CLINICAL RESEARCH EXPERIENCE INCLUDING DEVELOPMENT LEADERSHIP ROLES IN MEDICAL MARKETING, FULL CLINICAL DEVELOPMENT, EARLY DEVELOPMENT, AND TRANSLATIONAL AND BIOMARKER SCIENCES IN PSYCHIATRY AND NEUROLOGY. DURING HER TENURE AT JOHNSON & JOHNSON, SHE SUCCESSFULLY FILED NDAS IN THE US AND EUROPE FOR RISPERIDONE INDICATIONS IN AUTISM, ADOLESCENT SCHIZOPHRENIA, JUVENILE BIPOLAR DISORDER AND CONDUCT DISORDERS. SHE ALSO LED DEVELOPMENT TEAMS EVALUATING COMPOUNDS FOR DEPRESSION, NEUROPATHIC PAIN, EPILEPSY, AND MIGRAINE DISORDER. SHE SERVED 3 YEARS AS CHIEF SCIENCE AND TECHNOLOGY OFFICER FOR ONE MIND FOR RESEARCH, A NONPROFIT ORGANIZATION LAUNCHED IN MAY 2012 BY PATRICK J KENNEDY. SHE ORCHESTRATED THE LAUNCH OF ONE MIND'S SEMINAL PROGRAMS, APOLLO, AN INFORMATICS RESEARCH PORTAL AND, GEMINI, AN INTERNATIONAL TBI/PTSD RESEARCH PROGRAM. AS AN "INTRAPRENEUR" AT J&J SHE ESTABLISHED THE FIRST NEUROSCIENCE TRANSLATIONAL MEDICINE & INTEGRATIVE SOLUTIONS DEPARTMENT, AND CO-FOUNDED THE FIRST COMPANION DIAGNOSTICS CENTER OF EXCELLENCE AS WELL AS J&J'S HEALTHCARE INNOVATION TEAM. SHE SERVES ON SEVERAL ADVISORY BOARDS INCLUDING ALTO NEUROSCIENCE, KREMBIL CENTRE FOR NEUROINFORMATICS, VIRTUALBRAINCLOUD, PARTNERSHIP FOR ASSESSMENT AND ACCREDITATION OF SCIENTIFIC PRACTICE (PAASP) AND INTERUNIVERSITY MICROELECTRONICS CENTRE (IMEC) AN INTERNATIONAL RESEARCH & DEVELOPMENT AND INNOVATION HUB. DR. HAAS EARNED HER BS IN BIOENGINEERING FROM THE UNIVERSITY OF PENNSYLVANIA, AN MS IN BIOMEDICAL ENGINEERING FROM RUTGERS UNIVERSITY, NEW JERSEY, AND HER MD PHD WITH DISTINCTION IN NEUROSCIENCE FROM ALBERT EINSTEIN COLLEGE OF MEDICINE, NEW YORK. BOARD MEMBER, SECRETARY, THERESA FRANGIOSA HAS EXTENSIVE EXECUTIVE EXPERIENCED BASED ON HER 25 YEAR CAREER WITH THE PHARMACEUTICAL SECTOR. IN HER ROLES WITHIN PHARMA, SHE WAS A GLOBAL LAUNCH LEADER AS WELL AS OVERSEEING EARLY COMMERCIAL STRATEGY IN NEUROSCIENCES. SHE LED LARGE SCALE TEAMS, CROSS-FUNCTIONAL TEAMS TO DEFINE DISEASE AND THERAPEUTIC AREA STRATEGIES FOR JANSSEN AND GLAXOSMITHKLINE. SHE HAS ALSO LED INDICATION PRIORITIZATION EFFORTS AND DEVELOPMENT OF OVER 200 TARGET PRODUCT PROFILES OVER A VARIETY OF DISEASE STATES, LEVERAGING WELL-ESTABLISHED PROCESSES AND FRAMEWORKS, INCLUDING DEEPER UNDERSTANDING OF PATIENT JOURNEYS TO CREATE KEY INSIGHTS. SHE HAS APPLIED HER PROFESSIONAL CAREER EXPERIENCE AND HER PASSION FOR ADVOCACY TO HELP CREATE A CHANNEL FOR FEEDBACK FROM THOSE DIAGNOSED WITH OR AT RISK FOR ALZHEIMER'S DISEASE OR DEMENTIA, THEIR CARE PARTNERS AND INDIVIDUALS WHO ARE 'WORRIED WELL', CALLED THE A-LIST. SHE IS THE LEAD INVESTIGATOR FOR THIS RESEARCH STUDY WITH IRB OVERSIGHT. MS. FRANGIOSA OBTAINED HER BACHELOR OF ADMINISTRATION, ACCOUNTING CONCENTRATION FROM URSINUS COLLEGE (COLLEGEVILLE, PA) IN 1988 AND HER MASTERS OF BUSINESS ADMINISTRATION, PHARMACEUTICAL MARKETING FROM ST. JOSEPH'S UNIVERSITY IN 1996. BOARD MEMBER, TREASURER, MICHAEL C. SULLIVAN IS THE CHIEF OF STAFF AND HEAD OF EXTERNAL AFFAIRS OF POINT72 ASSET MANAGEMENT. MR. SULLIVAN PREVIOUSLY SERVED AS A SENIOR AIDE IN THE UNITED STATES SENATE, FOCUSING ON TELECOM, TECHNOLOGY, AND FINANCE ISSUES. MR. SULLIVAN ALSO SERVED AS A STAFF MEMBER IN THE U.S. HOUSE OF REPRESENTATIVES WORKING ON SIMILAR ISSUES. BEFORE COMING TO CAPITOL HILL, MR. SULLIVAN WAS THE HEAD OF STRATEGIC DEVELOPMENT FOR A TELECOMMUNICATIONS FOCUSED TRADE ASSOCIATION. MR. SULLIVAN IS INVOLVED WITH SEVERAL VETERANS' MENTAL HEALTH-RELATED NON-PROFIT ORGANIZATIONS. HE HELPED ESTABLISH AND SERVES ON THE BOARD AND AS TREASURER OF THE COHEN VETERANS NETWORK, WHICH OPERATES A NATIONAL NETWORK OF CLINICS TO TREAT VETERANS AND THEIR FAMILY MEMBERS AFFECTED BY POST-TRAUMATIC STRESS. MR. SULLIVAN IS AN ASSOCIATE AT THE NYU-STERN ENDLESS FRONTIER LABS, WHERE HE MENTORS START-UP COMPANIES IN ARTIFICIAL INTELLIGENCE, MACHINE LEARNING, AND RELATED FIELDS. HE IS ALSO A MEMBER OF THE EXECUTIVE COMMITTEE OF STUDENTS FIRST NEW YORK, A NONPROFIT
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt2AS A MEMBER OF THE SANOFI AVENTIS NA DERMATOLOGY LEADERSHIP TEAM, DAVE DEVELOPED THE GLOBAL AESTHETIC FRANCHISE STRATEGY AND SERVED AS THE COMMERCIAL HEAD FOR EUROPE. FOR THIS TURNAROUND PROJECT, HE CREATED A PLAN TO TRIPLE EBITDA, IMPLEMENT NEW GLOBAL PRICING POLICIES AND DOUBLE CUSTOMER ACQUISITION. DAVE RECEIVED HIS B.S. FROM GROVE CITY COLLEGE AND PH.D. IN CHEMISTRY FROM PURDUE UNIVERSITY. BOARD MEMBER, DOUG HAYNES IS AN ACTIVE COMMUNITY MEMBER, DEDICATING A SIGNIFICANT PORTION OF HIS EFFORTS TO SUPPORTING VETERANS' INITIATIVES. IN ADDITION TO SERVING ON THE BOARD OF THE ROBIN HOOD FOUNDATION, MR. HAYNES HELPED LAUNCH ITS VETERANS ADVISORY BOARD WHICH RAISED OVER $12 MILLION TO SUPPORT THE INCREASE IN VETERANS RETURNING FROM IRAQ AND AFGHANISTAN, AND ALSO WORKS WITH NEW YORK-BASED COMPANIES TO CREATE MORE JOB OPPORTUNITIES FOR VETERANS. MR. HAYNES SERVES ON THE CORPORATE ADVISORY BOARD OF THE DARDEN GRADUATE SCHOOL OF BUSINESS, THE BOARD OF THE CANTERBURY SCHOOL, SINGTEL'S TECHNOLOGY ADVISORY BOARD, AND THE BOARD OF THE CENTER FOR GLOBAL ENTERPRISE. MR. HAYNES FORMERLY SERVED AS THE PRESIDENT OF POINT72 ASSET MANAGEMENT, L.P., ORIGINALLY JOINING THE FIRM AS MANAGING DIRECTOR OF HUMAN CAPITAL IN FEBRUARY 2014. PRIOR TO JOINING POINT72, MR. HAYNES WAS A DIRECTOR AT MCKINSEY & COMPANY. BEFORE JOINING MCKINSEY, MR. HAYNES WORKED FOR THE CENTRAL INTELLIGENCE AGENCY AND THEN GE'S ADVANCED MATERIALS BUSINESS. MR. HAYNES EARNED A BS SUMMA CUM LAUDE IN MECHANICAL ENGINEERING FROM WEST VIRGINIA UNIVERSITY, AND RECEIVED HIS MBA AT THE UNIVERSITY OF VIRGINIA'S DARDEN GRADUATE BUSINESS SCHOOL, WHERE HE WAS A SHERMET SCHOLAR.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc1PART II SECT C LINE 17A FACTS & CIRCUMSTANCES TEST (CONT):
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc2PART II SECT C LINE 17A FACTS & CIRCUMSTANCES TEST (CONT):
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt016160581
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt016316026
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt020795052
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt016828176
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt04366629
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt074466464
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt059585
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0154639

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2021 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$17,952,584
Liabilities
$6,826,523
Net assets
$11,126,061
Revenue
$16,252,270
Expenses
$18,110,420
Net income
-$1,858,150
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.84$0.10$1.74$3.37$1.38$1.99
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.08$3.11$0.03$8.38$14.1$5.70
2023Facts available. Structured filing facts are available, but richer extracted sections are limited.$11.7$3.85$7.89$11.3$15.3$4.00
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$15.6$3.70$11.9$18.1$17.5$0.56
2021Detailed filing. Detailed filing data is available for this year.$18.0$6.83$11.1$16.3$18.1$1.86
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$18.9$8.43$10.4$16.5$18.2$1.69
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$24.2$13.0$11.2$21.0$20.2$0.87
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$16.4$6.02$10.3$16.8$14.8$2.05
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$14.9$6.58$8.28$4.37$11.3$6.97
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$25.4$10.2$15.3$31.4$16.3$15.1
2015Detailed filing. Detailed filing data is available for this year.$0.45$0.33$0.12$0.07$0.65$0.58